Quotient Sciences’ team has an in-depth understanding of the evolving clinical trial regulatory environment in Europe and the US, ensuring the production of high-quality dossiers and a seamless submission and approval process for your Phase I clinical trial application.
We have strong collaborative relationships with IRBs/RECs in the UK and US, with combined in-depth and up-to-date understanding of the clinical trial regulatory environment and requirements, which results in high-quality submissions and fast approvals.
Regulatory affairs